Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Omar Serang and Jason Moore

Premium

DNANexus said this week that it has hired Omar Serang to be its chief cloud officer.

In his new role, Serang will work with DNANexus' product management and engineering teams to improve its cloud functionality and increase adoption of cloud-based service for analyzing and managing DNA data. He'll also be responsible for driving product development roadmaps and managing compliance and integration efforts as well as evaluating, designing, and implementing cloud security and governance features.

He joins the company from Amazon Web Services where he formed its Enterprise Cloud Transformation consulting practice and was responsible for designing and deploying cloud architectures as well as providing roadmap guidance to AWS service teams. Prior to that, he was an operations engineering manager at AWS and was responsible for its Elastic Compute Cloud service quality. Serang has also served in senior operations positions at Topsy Labs, Cloudmark and Critical Path.

He holds a BS degree from the University of California, Berkeley.


Jason Moore, a professor in Dartmouth College's Geisel School of Medicine has been named a Kavli Fellow of the National Academy of Sciences for 2013 for his work in translational bioinformatics and personalized medicine.

Moore is a professor of genetics and of community and family medicine at Geisel, director of Dartmouth's Institute for Quantitative Biomedical Sciences, and associate director for bioinformatics at Norris Cotton Cancer Center at Dartmouth.

He obtained his BS in biological sciences from Florida State University; and an MS in human genetics, an MA in applied statistics, and a PhD in human genetics all from the University of Michigan.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.